FindTrial
Sign In

To study the characteristics and outcomes of cancer patients with coronavirus (Covid 19) admitted to the intensive care unit in a Cancer Centre

To evaluate the characteristics and outcomes of cancer patients with coronavirus (Covid 19) admitted to the intensive care unit in a Tertiary Cancer Centre and identify risk factors that predict outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034301
Enrollment
500
Registered
2021-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients >18 years diagnosed with Covid-19 admitted to the Intensive Care unit in TMH

Exclusion criteria

Exclusion criteria: Post Bone Marrow transplant

Design outcomes

Primary

MeasureTime frame
Mortality in the ICU for cancer patients with covid-19Timepoint: At 30 day—

Secondary

MeasureTime frame
In-hospital mortality and 30-day mortality for cancer patients with covid-19Timepoint: At 30 day—

Countries

India

Contacts

Public ContactDr J V Divatia

Tata Memorial Centre

jdivatia@yahoo.com02224177041

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026